AxoGen, Inc. (AXGN) is a Medical - Devices company in the Healthcare sector, currently trading at $34.46. It has a SharesGrow Score of 52/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AXGN = $3.60 (-89.6% from the current price, the stock appears overvalued). Analyst consensus target is AXGN = $38 (+11.4% upside).
Valuation: AXGN trades at a trailing Price-to-Earnings (P/E) of -102.6 (S&P 500 average ~25).
Financials: revenue is $225M, +17.6%/yr average growth. Net income is $16M (loss), growing at +5.7%/yr. Net profit margin is -7% (negative). Gross margin is 74.3% (-8.3 pp trend).
Balance sheet: total debt is $19M against $129M equity (Debt-to-Equity (D/E) ratio 0.15, conservative). Current ratio is 5.11 (strong liquidity). Debt-to-assets is 8.7%. Total assets: $222M.
Analyst outlook: 15 / 18 analysts rate AXGN as buy (83%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 73/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 55/100 (Partial), Future 82/100 (Pass), Income 10/100 (Fail).
